Transcat, Inc.

TRNS

CIK 0000099302 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-27) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$84M
↑+25.6% +$17Mvs FY2024 (Q4)
Operating Income
$88K
↓-95.8% -$2Mvs FY2024 (Q4)
Gross Profit
$25M
↑+28.3% +$6Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
48/100
  • Profitability
    1ROIC 5.2% (10% = solid, 20%+ = moat)
  • Liquidity
    90Current Ratio 2.29 (above 1.5 = solid)
  • Leverage
    95D/E 0.11 (under 0.5 = conservative)
  • Efficiency
    48Asset Turnover 0.83x (1.0+ = capital-efficient)
  • Growth
    46Revenue YoY +8.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    8Op Margin 0.1% · trend -2.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project TRNS's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 51.2%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$92.95
Total enterprise IV
$860M
Diluted shares
0.01B
Terminal PV
$668M (78% of total)
Year-5 FCF
$79M
YearProjected FCFDiscounted PV
+1$32M$29M
+2$40M$33M
+3$50M$38M
+4$63M$43M
+5$79M$49M
Terminal$1.08B$668M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$14M
investment in PP&E
Stock buybacks (TTM)
$467K
share count reduction
Stock-based comp (TTM)
$6M
non-cash dilution

Balance sheet · 2025-12-27

latest filed snapshot
Total assets
$473M
everything owned
Total liabilities
$176M
everything owed
Stockholders' equity
$297M
shareholder claim
Net debt
$96M
LT debt minus cash

Recent performance · 64 quarters

Revenue↑+8.7% +$7M
$84M
Net Income↓-124.7% -$6M
$-1M
Free Cash Flow↓-2.7% -$263K
$9M
Operating Margin↓-8.9pts
0.1%

Drill down